Gail Mannix »

Bicycle Therapeutics shares owned by Gail Mannix

Quarter-by-quarter ownership of Bicycle Therapeutics (BCYC) shares owned by Gail Mannix from 13F filings

Historical chart of Gail Mannix investment in Bicycle Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bicycle Therapeutics held by Gail Mannix consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bicycle Therapeutics by Gail Mannix

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.0M 80k 24.90

More positions owned by Gail Mannix

Apple (AAPL)
Johnson & Johnson (JNJ)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Small Cp Etf (VB)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Lam Research Corporation (LRCX)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Xylem (XYL)
Regeneron Pharmaceuticals (REGN)

View all positions for Gail Mannix

Top funds holding Bicycle Therapeutics

Paradigm Biocapital Advisors
Baker Bros. Advisors
First Light Asset Management
Westfield Capital Management Company
Candriam Luxembourg S.C.A.
Bnp Paribas Investment Partners
Ridgeback Capital Investments
RA Capital Management
BlackRock
Bank of America Corporation
Nomura Holdings
Verition Fund Management
Platinum Investment Mangement
Citadel Advisors
T. Rowe Price Associates

View all funds holding Bicycle Therapeutics